These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33048837)

  • 1. Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.
    Zemanova M; Jakopovic M; Stanic K; Łazar-Poniatowska M; Vrankar M; Rusu P; Ciuleanu T; Radosavljevic D; Bogos K; Nawrocki S
    Radiol Oncol; 2020 Oct; 54(4):447-454. PubMed ID: 33048837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
    Evison M; Edwards J; McDonald F; Popat S
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
    Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
    Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study.
    Auliac JB; Greillier L; Martin E; Falcoz PE; Boisselier P; Ano S; Lefrançois M; Cortot A
    Respir Med Res; 2024 Jun; 85():101087. PubMed ID: 38657298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality indicators for non-small cell lung cancer operations with use of a modified Delphi consensus process.
    Darling G; Malthaner R; Dickie J; McKnight L; Nhan C; Hunter A; McLeod RS;
    Ann Thorac Surg; 2014 Jul; 98(1):183-90. PubMed ID: 24775804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists.
    Nindra U; Bray V; Karikios D; Shafiei M; Subramaniam S; Ding P; Kao S; Pal A
    Oncology; 2024; 102(8):732-736. PubMed ID: 38232722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
    Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
    JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study.
    Isla D; Felip E; Garrido P; Insa A; Majem M; Remon J; Trigo JM; de Castro J
    Clin Transl Oncol; 2023 Jan; 25(1):283-291. PubMed ID: 36168085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.
    Ramella S; Maranzano E; Frata P; Mantovani C; Lazzari G; Menichelli C; Navarria P; Pergolizzi S; Salvi F
    Tumori; 2012; 98(1):66-78. PubMed ID: 22495704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
    Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018.
    Robinson D; Hawthorne S; Zhao L; Hanson M; Kanas G; Davis C; Clark O
    Future Oncol; 2020 Mar; 16(7):255-262. PubMed ID: 32019323
    [No Abstract]   [Full Text] [Related]  

  • 13. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
    Putora PM; Glatzer M; De Ruysscher D; Faivre-Finn C; Belderbos J; Besse B; Blackhall F; Califano R; Cappuzzo F; de Marinis F; Dziadiuszko R; Felip E; Früh M; Garrido P; Le Pechoux C; McDonald F; Nestle U; Novello S; Brien MO; Paz Ares L; Peeters S; Pöttgen C; Ramella S; Reck M; Troost EGC; Van Houtte P; Westeel V; Widder J; Mornex F; Slotman BJ
    Radiother Oncol; 2019 Jun; 135():74-77. PubMed ID: 31015173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
    Zemanova M; Pirker R; Petruzelka L; Zbozínkova Z; Jovanovic D; Rajer M; Bogos K; Purkalne G; Ceriman V; Chaudhary S; Richter I; Kufa J; Jakubikova L; Zemaitis M; Cernovska M; Koubkova L; Vilasova Z; Dieckmann K; Farkas A; Spasic J; Fröhlich K; Tiefenbacher A; Hollosi V; Kultan J; Kolarová I; Votruba J
    Radiol Oncol; 2020 May; 54(2):209-220. PubMed ID: 32463394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
    Ospina AV; Bolufer Nadal S; Campo-Cañaveral de la Cruz JL; González Larriba JL; Macía Vidueira I; Massutí Sureda B; Nadal E; Trancho FH; Álvarez Kindelán A; Del Barco Morillo E; Bernabé Caro R; Bosch Barrera J; Calvo de Juan V; Casal Rubio J; de Castro J; Cilleruelo Ramos Á; Cobo Dols M; Dómine Gómez M; Figueroa Almánzar S; Garcia Campelo R; Insa Mollá A; Jarabo Sarceda JR; Jiménez Maestre U; López Castro R; Majem M; Martinez-Marti A; Martínez Téllez E; Sánchez Lorente D; Provencio M
    Clin Transl Oncol; 2024 Jul; 26(7):1647-1663. PubMed ID: 38530556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.
    Girard N; Corral J; Cortinovis D; Heigener DF
    Clin Lung Cancer; 2017 Mar; 18(2):e89-e97. PubMed ID: 27865625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
    Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
    Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
    J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
    Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
    Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.